Cargando…
Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism
SUMMARY: Although bone disease and stone disease are the universally accepted classical manifestations of primary hyperparathyroidism, clinical parathyroid bone disease is rarely seen today in the United States (<5% of patients) and Western Europe. Nevertheless, in a given patient, classical skel...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671544/ https://www.ncbi.nlm.nih.gov/pubmed/28900835 http://dx.doi.org/10.1007/s12020-017-1414-2 |
_version_ | 1783276255455477760 |
---|---|
author | Misiorowski, Waldemar Czajka-Oraniec, Izabela Kochman, Magdalena Zgliczyński, Wojciech Bilezikian, John P. |
author_facet | Misiorowski, Waldemar Czajka-Oraniec, Izabela Kochman, Magdalena Zgliczyński, Wojciech Bilezikian, John P. |
author_sort | Misiorowski, Waldemar |
collection | PubMed |
description | SUMMARY: Although bone disease and stone disease are the universally accepted classical manifestations of primary hyperparathyroidism, clinical parathyroid bone disease is rarely seen today in the United States (<5% of patients) and Western Europe. Nevertheless, in a given patient, classical skeletal involvement can be the first sign of primary hyperparathyroidism, but not recognized because it is not usually included, anymore, in the differential diagnosis of this manifestation of skeletal disease. We describe four cases of primary hyperparathyroidism in which the first clinical manifestation of the disease was a pathological fracture that masqueraded as a malignancy. The presence of large osteolytic lesions gave rise to the initial diagnosis of a primary or metastatic cancer. In none of the reported cases was primary hyperparathyroidism with osteitis fibrosa considered as the diagnosis. It would seem to us that this course is best explained by the fact that in many countries such manifestations of primary hyperparathyroidism have become a rarity. In fact, the incidence of osteitis fibrosa among patients with primary hyperparathyroidism in the US is estimated as so rare, that in majority of medical centers routine x-ray examinations of the bones in these patients is not recommended. The X-ray or computed tomography scan findings of osteitis fibrosa cystica include lytic or multilobular cystic changes. Multiple bony lesions representing brown tumors may be misdiagnosed on computed tomography scan as metastatic carcinoma, bone cysts, osteosarcoma, and especially giant-cell tumor. Distinguishing between primary hyperparathyroidism and malignancy is made readily by the concomitant measurement of parathyroid hormone which in primary hyperparathyroidism, again, will be markedly elevated. In the hypercalcemias of malignancy, such elevations of parathyroid hormone are virtually never seen. CONCLUSION: When radiographic evidence of a lytic lesion and hypercalcemia are present, primary hyperparathyroidism should always be considered in the differential diagnosis. |
format | Online Article Text |
id | pubmed-5671544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-56715442017-11-17 Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism Misiorowski, Waldemar Czajka-Oraniec, Izabela Kochman, Magdalena Zgliczyński, Wojciech Bilezikian, John P. Endocrine Clinical Management of Endocrine Diseases SUMMARY: Although bone disease and stone disease are the universally accepted classical manifestations of primary hyperparathyroidism, clinical parathyroid bone disease is rarely seen today in the United States (<5% of patients) and Western Europe. Nevertheless, in a given patient, classical skeletal involvement can be the first sign of primary hyperparathyroidism, but not recognized because it is not usually included, anymore, in the differential diagnosis of this manifestation of skeletal disease. We describe four cases of primary hyperparathyroidism in which the first clinical manifestation of the disease was a pathological fracture that masqueraded as a malignancy. The presence of large osteolytic lesions gave rise to the initial diagnosis of a primary or metastatic cancer. In none of the reported cases was primary hyperparathyroidism with osteitis fibrosa considered as the diagnosis. It would seem to us that this course is best explained by the fact that in many countries such manifestations of primary hyperparathyroidism have become a rarity. In fact, the incidence of osteitis fibrosa among patients with primary hyperparathyroidism in the US is estimated as so rare, that in majority of medical centers routine x-ray examinations of the bones in these patients is not recommended. The X-ray or computed tomography scan findings of osteitis fibrosa cystica include lytic or multilobular cystic changes. Multiple bony lesions representing brown tumors may be misdiagnosed on computed tomography scan as metastatic carcinoma, bone cysts, osteosarcoma, and especially giant-cell tumor. Distinguishing between primary hyperparathyroidism and malignancy is made readily by the concomitant measurement of parathyroid hormone which in primary hyperparathyroidism, again, will be markedly elevated. In the hypercalcemias of malignancy, such elevations of parathyroid hormone are virtually never seen. CONCLUSION: When radiographic evidence of a lytic lesion and hypercalcemia are present, primary hyperparathyroidism should always be considered in the differential diagnosis. Springer US 2017-09-12 2017 /pmc/articles/PMC5671544/ /pubmed/28900835 http://dx.doi.org/10.1007/s12020-017-1414-2 Text en © The Author(s) 2017 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Clinical Management of Endocrine Diseases Misiorowski, Waldemar Czajka-Oraniec, Izabela Kochman, Magdalena Zgliczyński, Wojciech Bilezikian, John P. Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism |
title | Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism |
title_full | Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism |
title_fullStr | Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism |
title_full_unstemmed | Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism |
title_short | Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism |
title_sort | osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism |
topic | Clinical Management of Endocrine Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671544/ https://www.ncbi.nlm.nih.gov/pubmed/28900835 http://dx.doi.org/10.1007/s12020-017-1414-2 |
work_keys_str_mv | AT misiorowskiwaldemar osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism AT czajkaoraniecizabela osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism AT kochmanmagdalena osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism AT zgliczynskiwojciech osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism AT bilezikianjohnp osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism |